NASDAQ
Marker Therapeutics, Inc. (MRKR) has a free cash flow growth of 26.10% as of Friday, May 29, 2026. This represents a 208.82% increase compared to its 12-month average of 8.45%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.